采用阳性症状量表和阴性症状量表(PANSS)以评定齐拉西酮对女性精神分裂症的疗效，采用不良反应量表(TESS)评定该药物的副反应。
The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.
治疗结束后分别对患者睡眠障碍量表(SDRS)评分、血糖水平、不良反应进行分析。
Sleep Dysfunction Rating Scale (SDRS) score, blood glucose level and the adverse reactions in the two groups were analyzed.
采用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表(CGI)、副反应量表(TESS)评定疗效及不良反应。
Hamilton depression rating scale (HAMD), clinical general impressional scale (CGI) and treatment emergent symptom scale (TESS) were assessed.
疗效和不良反应分别用简明精神病评定量表（BPRS）和副反应量表（TESS）进行评定，并测定治疗第1，2，4，6周的稳态血药浓度。
Therapeutic efficacy was measured by BPRS and the adverse reaction was rated by TESS. Steady serum level was monitored within 1, 2, 4, 6 week.
治疗前后采用PD评定量表(UPDRS)对疗效进行评估，并记录患者不良反应。
Before and after treatment with PD Rating Scale (UPDRS) assessment of the efficacy and adverse reactions were recorded.
采用治疗中需处理的不良反应症状量表(TESS)评定安全性。
Treatment emergent symptoms scale (TESS) was used to evaluate the safety.
采用阳性与阴性症状量表（PANSS）评定疗效，副反应量表（TESS）评定不良反应。
Positive and Negative Syndrome Scale (PANSS) was used to assess the efficacy, side effects scale (TESS) was used to assess adverse reactions.
以阳性和阴性症状量表（PANSS）评定临床疗效，以副反应量表（TESS）评定不良反应。
The efficacy was evaluated by positive and negative symptom scale(PANSS), and the side effects by treatment emergent symptom scale(TESS).
采用异常不自主运动量表（AIMS）和简明精神病评定量表（BPRS）及副反应量表（TESS）在治疗前及治疗后1、2、4、6周末分别评定疗效及不良反应。
The efficacy and safety were assessed with AIMS, BPRS and TESS at the end of week 1,2,4 and 6.
疗程6周，采用汉密尔顿抑郁量表(HAMD)和副反应量表(tess)法，在治疗前，治疗后第1,2,4,6周，分别评定药物疗效和不良反应。
HAMD and TESS were used to assess the efficacy and side effects before the treatment and 1st week, 2nd week, 4th week and 6th week after it.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
PANSS and TESS were used to assess the clinic and side effects.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.
应用推荐